reduced nicotinamide mononucleotide（NMNH） NEW

$0.00 25kg

$0.00 1kg

Min. Order1kg
Purity0.99
Cas No108347-85-9
Supply Ability20tons
Update time2026-04-10

HANGZHOU INVERTIN BIOPHARMA CO., LTD.

VIP1Y

China

Since:2022-07-21

Address:Room 306, 3rd Floor, Building 3, No. 516 Renhe Avenue, Renhe Street, Yuhang District, Hangzhou, Zhej

show less show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	reduced nicotinamide mononucleotide（NMNH）
CAS No	108347-85-9
EC-No
Min. Order	1kg
Purity	0.99
Supply Ability	20tons
Release date	2026/04/10

Reduced Nicotinamide Mononucleotide (NMNH) is an advanced NAD+ precursor nutraceutical ingredient widely used in dietary supplements and functional health products.

As a reduced form of NMN, NMNH plays an important role in cellular energy metabolism and NAD+ level support, making it an emerging ingredient in the anti-aging and wellness market.

This ingredient is increasingly applied in energy support, metabolic health, and healthy aging formulations, and is gaining attention among supplement brands and research institutions.

NMNH is commonly used as a dietary supplement raw material in products targeting cellular vitality, energy production, and overall wellness.

With growing interest in NAD+ boosting ingredients and anti-aging nutraceuticals, reduced nicotinamide mononucleotide (NMNH) is becoming a promising option for innovative supplement formulations.

Reduced Nicotinamide Mononucleotide (NMNH) is a next-generation NAD+ precursor ingredient for energy metabolism and anti-aging nutraceutical applications.

show less show more

Company Profile Introduction

HANGZHOU INVERTIN BIOPHARMA CO., LTD. is a rapidly developing green biosynthesis enterprise in the biochemical industry. With technological innovation as our core competitiveness, we focus on R&D, production, sales and technical services of functional active substances, cosmetic ingredients, pharmaceutical chemicals and intermediates, and industrial enzyme preparations. We have mature technologies in microbial engineering, biocatalysts and biocatalytic processes, with core advantages in strain modification, fermentation, biotransformation and industrial production. Our quality control laboratory and sterile workshop meet relevant national standards and API requirements, ensuring stable product quality. Our R&D team consists of doctors, masters and senior engineers from well-known universities at home and abroad. The company owns 8 invention patents, was awarded Zhejiang Science and Technology-based SME in 2021 and selected into the South Taihu Elite Program in 2022. We maintain close industry-university-research cooperation to accelerate technology transformation. We provide customized services from lab R&D to industrial production, and supply fine chemicals and enzyme preparations. We have established long-term cooperation with enterprises in pharmaceutical, food, health products and cosmetics industries. In the future, we will continue to innovate green biosynthesis technology and promote low-carbon development in the functional raw material sector. ?